Lazard Asset Management
SRPT icon

Lazard Asset Management’s Sarepta Therapeutics SRPT Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$7K Sell
445
-4,340
-91% -$68.3K ﹤0.01% 2186
2025
Q1
$304K Buy
4,785
+2,590
+118% +$165K ﹤0.01% 1528
2024
Q4
$265K Sell
2,195
-78
-3% -$9.42K ﹤0.01% 1532
2024
Q3
$283K Sell
2,273
-563
-20% -$70.1K ﹤0.01% 1528
2024
Q2
$446K Buy
2,836
+299
+12% +$47K ﹤0.01% 1242
2024
Q1
$328K Buy
2,537
+152
+6% +$19.7K ﹤0.01% 1157
2023
Q4
$229K Buy
2,385
+60
+3% +$5.76K ﹤0.01% 1339
2023
Q3
$280K Buy
2,325
+1,190
+105% +$143K ﹤0.01% 1279
2023
Q2
$128K Buy
1,135
+455
+67% +$51.3K ﹤0.01% 1492
2023
Q1
$93K Buy
680
+57
+9% +$7.8K ﹤0.01% 1557
2022
Q4
$79K Sell
623
-1,090
-64% -$138K ﹤0.01% 1614
2022
Q3
$188K Buy
1,713
+649
+61% +$71.2K ﹤0.01% 1280
2022
Q2
$79K Buy
1,064
+41
+4% +$3.04K ﹤0.01% 1606
2022
Q1
$79K Sell
1,023
-420
-29% -$32.4K ﹤0.01% 1509
2021
Q4
$129K Sell
1,443
-315
-18% -$28.2K ﹤0.01% 1370
2021
Q3
$162K Sell
1,758
-185
-10% -$17K ﹤0.01% 1321
2021
Q2
$150K Sell
1,943
-4,568
-70% -$353K ﹤0.01% 1260
2021
Q1
$485K Sell
6,511
-23,194
-78% -$1.73M ﹤0.01% 987
2020
Q4
$5.06M Buy
29,705
+29,308
+7,382% +$5M 0.01% 654
2020
Q3
$55K Sell
397
-155
-28% -$21.5K ﹤0.01% 1161
2020
Q2
$88K Sell
552
-560
-50% -$89.3K ﹤0.01% 1051
2020
Q1
$108K Buy
1,112
+1,088
+4,533% +$106K ﹤0.01% 987
2019
Q4
$3K Sell
24
-150
-86% -$18.8K ﹤0.01% 1460
2019
Q3
$13K Buy
+174
New +$13K ﹤0.01% 1234
2019
Q1
Sell
-1,000
Closed -$109K 1200
2018
Q4
$109K Hold
1,000
﹤0.01% 909
2018
Q3
$161K Sell
1,000
-6,370
-86% -$1.03M ﹤0.01% 893
2018
Q2
$973K Buy
+7,370
New +$973K ﹤0.01% 728